MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study (Q84966679)
Jump to navigation
Jump to search
scientific article published on 01 December 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study |
scientific article published on 01 December 2009 |
Statements
MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study (English)
Paul P Tak
Lisa von Moltke
Clarissa E Vergunst
Danielle M Gerlag
Michael Karol
Tim Wyant
Xuedong Chi
Ellen Matzkin
1 December 2009